Best Peptides for Muscle Building: IGF-1, GHRP-6, and Growth Hormone Secretagogues

By Justin Cartier

Research peptides covered in this growth-hormone guide

Growth-hormone research peptides fall into a few mechanism families. Some are GHRH analogs that prompt the pituitary to release growth hormone; others are ghrelin-receptor secretagogues (the GHRPs) that trigger a release pulse; and a third group acts through growth-factor pathways. Each compound has its own detailed guide, with specifications on the linked product pages.

GHRH analogs

CJC-1295 is a long-acting GHRH analog studied for sustained growth-hormone release — see the CJC-1295 guide or product page. Sermorelin is a shorter GHRH fragment — the Sermorelin guide covers it. Tesamorelin is a GHRH analog studied specifically for visceral fat — see the Tesamorelin guide or product page.

Ghrelin-receptor secretagogues (GHRPs)

Ipamorelin is a selective, clean secretagogue — read the Ipamorelin guide or view Ipamorelin. GHRP-6 is an older, appetite-stimulating GHRP — see the GHRP-6 guide. Hexarelin is a potent GHRP also studied for cardiovascular effects — the Hexarelin guide and product page cover it. These are often compared side by side — see GHRP-2 vs Hexarelin vs Ipamorelin and CJC-1295 vs Ipamorelin.

Growth-factor pathway compounds

Follistatin-344 is studied for its role in muscle-growth regulation — see the Follistatin-344 guide. IGF-1 LR3 is a long-acting form of insulin-like growth factor 1 — read the IGF-1 LR3 guide. MGF (mechano-growth factor) is a splice variant of IGF-1 studied for muscle repair — see the MGF guide.

The peptides people reach for to build muscle really sort into three camps, and which one is “best” depends entirely on your research goal. First up are the growth hormone peptides (CJC-1295, ipamorelin, GHRP-6, tesamorelin), which basically nudge the body into releasing its own growth hormone and, with it, more IGF-1. Then you’ve got the direct IGF-1 peptides (IGF-1 LR3, MGF), and these skip the middleman to switch on muscle protein synthesis themselves. Last is the myostatin blockers (follistatin 344), which take the brakes off growth entirely, and if you’ve ever seen a Belgian Blue bull, an animal born with a natural myostatin mutation, you already know how absurdly muscular that can get.

This article is for research and educational use only. These peptides are not approved for human use, and nothing here is medical advice.

Let’s be honest about the evidence up front, though. Growth hormone peptides clearly raise GH and IGF-1, but the actual muscle gains in healthy adults are smaller than those hormone numbers make you expect. IGF-1 LR3 lasts far longer than natural IGF-1, roughly 20 hours versus about 12 minutes, which makes it a great research tool, though very high doses can stop working as well because the receptor gets less sensitive. And follistatin produces huge gains in animals, but how well that carries over to humans is still very much an open question.

This guide walks through what each major muscle-growth peptide actually does, how the class compares with testosterone and anabolic steroids, which combinations have real additive evidence, what the safety picture looks like, and what to weigh when you design a muscle hypertrophy study.

What peptide is best for building muscle?

Honestly, the best peptides for muscle growth come down to the endpoint you care about, because they stimulate muscle growth in genuinely different ways, some chasing muscle strength and mass, others chasing repair. Chasing overall lean muscle and general mass gains in rodent and small human work? The CJC-1295 plus ipamorelin GH-axis stack has the deepest dataset. Want direct muscle protein synthesis without all the broad GH ripple effects instead? Then IGF-1 LR3 is the one that’s been studied hardest. Follistatin 344 takes the crown for myostatin-pathway work and the biggest absolute hypertrophy, while MGF is your pick when the question turns to satellite-cell activation and post-injury muscle repair. The whole game is matching the peptide to the question, not grabbing whatever’s trending.

Growth hormone secretagogues: CJC-1295, ipamorelin, GHRP-6

The growth hormone axis is the most-developed muscle application in research peptides, so start there. CJC-1295 is an analog of growth hormone-releasing hormone that raises your baseline GH and IGF-1. Peptides like ipamorelin are selective GH secretagogues that trigger a pulse, and together the two aim at increased muscle mass over time. Raun and colleagues, in the European Journal of Endocrinology, described ipamorelin as the first GHRP-receptor agonist selective for GH release, meaning it doesn’t also raise cortisol or prolactin the way older GHRPs like GHRP-2 and GHRP-6 do.^[1]

That’s exactly why the CJC-1295 and ipamorelin pairing is the canonical stack for muscle growth research: it teams a GHRH baseline-raiser with a pulse-triggering secretagogue. Together they amplify the body’s natural growth hormone rhythm instead of forcing a flat, artificial elevation. The catch is timing and size. The effect on lean mass shows up over 8 to 16 weeks of steady dosing, and it’s modest, a few percent, next to what anabolic steroids do.

IGF-1 and MGF: direct muscle-targeting peptides

IGF-1 LR3 is a souped-up version of the growth hormone axis’s own downstream messenger. It’s insulin-like growth factor-1 with an arginine swap and a 13-amino-acid extension tacked onto one end. Laajoki and colleagues, in the Journal of Biological Chemistry, worked out how that extension gives the LR3 variant a much longer half-life and weaker binding to the IGF binding proteins.^[2] The upshot is more free peptide available to hit muscle IGF-1 receptors and drive protein synthesis.

MGF, or mechano growth factor, is a different beast: a splice variant of IGF-1 the muscle makes itself after mechanical loading. Kandalla and colleagues, in Mechanisms of Ageing and Development, showed the MGF-E peptide extends the proliferative lifespan and delays the aging of satellite cells, the resident stem cells that repair and grow muscle after stress.^[3] That’s what makes MGF the most specific muscle-repair peptide of the bunch, since it works right at satellite-cell activation rather than through circulating GH or IGF-1.

Follistatin 344: myostatin inhibition

Myostatin, also called GDF-8, is the body’s built-in brake on muscle growth. Thies and colleagues, in Growth Factors, characterised GDF-8 as a TGF-beta family member that caps the maximum muscle mass you can reach through negative-feedback signalling.^[4] Knock that brake out and things get wild. Animals with natural myostatin mutations, the Belgian Blue cattle and the so-called “bully whippets,” pile on muscle as living proof of concept.

Follistatin 344 is the tool that mimics that. It binds myostatin in circulation and stops it from signalling. Lee, in Molecular Endocrinology, laid out how follistatin soaks up myostatin and activins, freeing up satellite-cell proliferation and muscle-fiber growth.^[5] In rodent models, follistatin 344 delivers the largest absolute lean-mass gains of any peptide in this guide, which is why it gets so much attention.

Is BPC-157 good for building muscle?

Not really, at least not directly. BPC-157 works on the eNOS-VEGF axis and is best known for tendon, ligament, gut-lining, and blood-vessel effects. It doesn’t stimulate growth hormone, doesn’t switch on IGF-1 signalling, and doesn’t touch myostatin. Where it earns a spot in muscle stacks is as a tissue-repair adjunct, helping you recover from the micro-damage of hard training, rather than as a direct growth stimulus. If your research is about muscle growth specifically, the GH-axis or IGF-1 peptides hit the mechanism far more directly.

How do peptides work for muscle growth?

The big idea behind using peptides is that these synthetic peptides work through specific receptors, not the broad androgen-receptor flood that drives steroids. That precision is what ties them to muscle growth and recovery rather than blanket anabolism. So where does each one actually plug in? The GH-axis peptides knock on GHRH or ghrelin receptors up in the pituitary, which lifts your own GH and, downstream, your IGF-1. IGF-1 LR3 and MGF cut out the middleman entirely and grab the IGF-1 receptor right on the muscle, kicking protein synthesis into gear through the PI3K-Akt-mTOR pathway. Follistatin does something sneakier, mopping myostatin out of the bloodstream so that brake never gets a chance to grip. And the repair crew, your BPC-157 and TB-500, aren’t chasing growth at all; they’re patching up tissue so you bounce back faster. That selective pharmacology is a double-edged sword. Peptides for muscle growth usually have narrower side effects than steroids. But they bring smaller absolute effects on lean mass, too.

How do peptides differ from steroids?

Anabolic steroids, think testosterone, nandrolone, trenbolone, switch on the androgen receptor in muscle and plenty of other tissues. That gives you broad anabolic, virilising, and heart-related effects all at once. Research peptides work much narrower axes, and once you line the two up the gaps get pretty stark. Take raw magnitude first. Steroids can slap on 5 to 15 percent lean mass in a matter of weeks, while peptides tend to manage 2 to 5 percent, and it takes them months to get there. The safety trade is just as lopsided. Steroids drag along heart, liver, fertility, and mood risks, whereas the peptides throw far quieter signals. Testing separates them, too, since steroids light up standard sports panels but plenty of GH secretagogues slip right past unless you run specialised assays. And under the hood they aren’t even playing the same game: steroids blast the androgen receptor body-wide, while peptides poke at one tissue-specific pathway at a time. So no, peptides aren’t a steroid stand-in on sheer size. They just live in a different corner of the map.

TRT vs peptides for muscle and recovery

Testosterone replacement therapy (TRT) is the clinical standard for diagnosed low testosterone in adult men. It brings serum testosterone back to the mid-normal range and delivers modest lean-mass gains along with the other testosterone effects. Peptides for muscle growth aren’t approved alternatives to TRT for that. In a research setting the two could even be run together, TRT for the hypogonadism and GH-axis peptides for extra GH and IGF-1 support, but TRT is the legally cleaner path for muscle within Canada and the United States. The peptides sit firmly in a research-only niche.

Common peptide stacks for muscle

A handful of research stacks come up again and again. CJC-1295 plus ipamorelin is the standard GH-axis pairing, usually dosed in the evening. Add IGF-1 LR3 to that and you layer direct receptor stimulation on top for muscle-specific hypertrophy work. Tesamorelin plus ipamorelin leans toward body-composition research, thanks to tesamorelin’s strong visceral-fat-reduction effect. BPC-157 plus TB-500 is the tissue-repair adjunct for high-volume training studies and faster recovery. And follistatin 344 usually runs alone, since it delivers the highest-magnitude lean-mass gains and gets stacked less often.

How long does it take to see results?

It varies a lot by mechanism. GH-axis peptides raise IGF-1 within days, but the lean-mass changes take 8 to 16 weeks. IGF-1 LR3 moves faster, 4 to 8 weeks, because it hits the receptor directly. Follistatin 344 shows visible hypertrophy in rodent models by week 4 to 6. MGF, used for satellite-cell research, shows effects over 2 to 4 weeks. What none of them do is produce the next-day strength jump some steroid users describe; the mechanisms here are gradual, not acute.

Side effects and safety

Most of these peptide therapies get studied for performance and recovery rather than for disease-driven muscle wasting or muscle breakdown, but the safety picture matters either way. Across the GH-axis peptides, the reported side effects in rodent and small human research are pretty minimal: injection-site irritation, some water retention, and a transient rise in blood sugar because GH pushes back against insulin. IGF-1 LR3 carries the biggest theoretical concern. IGF-1 is broadly mitogenic across many tissues, so chronic high-dose use raises worries about cancer-promoting potential, even though no clear signal has shown up in the published work. Follistatin 344’s long-term effects are the least mapped of all. That’s mostly because it also binds activin, a broader TGF-β family signal found in a lot of tissues.

Are peptides safe and legal for muscle building?

None of these peptides is approved by Health Canada or the FDA for building muscle. They’re all legal in Canada and the United States as research chemicals under research-use-only labelling, and that’s the whole picture on legality. On the anti-doping side, be careful: most GH-axis peptides (CJC-1295, ipamorelin, sermorelin, GHRP-6, tesamorelin, MGF) are on the World Anti-Doping Agency banned list, prohibited in and out of competition, and follistatin and IGF-1 LR3 are prohibited too. Use any of them in a sanctioned athletic context and you will fail testing.

Research-use-only labelling is what keeps these compounds legal to buy in Canada and the United States. Our guide to Canada’s peptide legal framework breaks down those rules and what to expect from a supplier.

Sourcing

A bad batch never announces itself. It just quietly ruins the data. If a vial holds the wrong peptide, a shortened sequence, or a load of synthesis by-products, your assays can fail outright, or worse, hand you clean-looking numbers that no other lab can repeat. You often will not know which until weeks of animal or cell work are already spent. That wasted time is the real cost of skipping verification, and it is why sourcing matters as much as study design. Before you commit any bench time, ask for a lot-specific analysis certificate from an outside lab, with HPLC purity and mass-spectrometry identity for each compound. For in-vivo or cell-culture work, endotoxin and sterility testing guard the experiment on top of that.

Reviv Peptides supplies the canonical muscle-growth research peptides with COA and HPLC purity confirmation. View the CJC-1295 + Ipamorelin Blend, or browse the full peptide catalogue for IGF-1 LR3, MGF, follistatin 344, and tesamorelin.

Best peptides for muscle building questions

What peptide is best for building muscle?

CJC-1295 plus ipamorelin for overall lean mass, IGF-1 LR3 for direct muscle protein synthesis, and follistatin 344 for the largest absolute hypertrophy effect. The right choice depends on your research endpoint.

Is BPC-157 good for building muscle?

Not directly. BPC-157 works on tissue repair and blood-vessel growth, which makes it a useful recovery adjunct in training research, but it isn’t a direct growth stimulus.

What is better, TRT or peptides?

TRT is the approved clinical standard for low testosterone in adult men. Peptides for muscle growth are research-only and not an approved TRT alternative, so the two really cover different regulatory and biological niches.

How do peptides work for muscle growth?

Through specific receptor binding: GH-axis peptides on pituitary GHRH and ghrelin receptors, IGF-1 LR3 on muscle IGF-1 receptors, and follistatin on circulating myostatin. That selective pharmacology gives smaller effects than steroids but narrower side-effect profiles.

Are peptides safe and legal for muscle building?

They’re legal in Canada and the United States as research chemicals only, and not approved for therapeutic use. Most are on the WADA banned list, which makes them unsuitable for any sanctioned athletic competition.

Key data point: Lee (2010, Molecular Endocrinology) showed that follistatin regulates muscle mass by binding and neutralising both myostatin and activins, and that raising follistatin frees satellite-cell proliferation and drives muscle-fiber growth, the mechanistic basis for why follistatin 344 produces the largest absolute lean-mass gains of any peptide in this class.^[5]

Summary

The best peptides for muscle building in the published research target three bottlenecks: the growth hormone axis (CJC-1295, ipamorelin, GHRP-6, sermorelin, tesamorelin), the IGF-1 axis (IGF-1 LR3, MGF), and the myostatin pathway (follistatin 344). Each camp addresses a different limiting step when you want to build muscle mass, so the smart move is to match your research question to the mechanism rather than pick on popularity. Effect sizes are modest next to anabolic steroids, but the side-effect profiles are much narrower. Everything on this list is research-only in Canada and the United States, and most are WADA-prohibited. Source carefully, run proper controls, and treat each peptide as a specific mechanistic probe rather than a general anabolic.

Sources

Sources: [1] Ipamorelin, the first selective GH secretagogue (Raun et al., 1998), PubMed/NIH. [2] Long-[Arg3]IGF-1 (IGF-1 LR3) structure and extended half-life (Laajoki et al., 2000), PubMed/NIH. [3] MGF-E peptide activates muscle satellite cells (Kandalla et al., 2011), PubMed/NIH. [4] Myostatin (GDF-8), a TGF-β family regulator of muscle (Thies et al., 2001), PubMed/NIH. [5] Regulation of muscle mass by follistatin and activins (Lee, 2010), PubMed/NIH.